Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Recent evidence suggests that children suffer adverse health effects from BLLs substantially lower than 10 µg/dL. Moreover, there is no level of exposure of lead that has found to be safe for children. Consequently it is important not only to eliminate the prevalence of children with elevated BLLs (i.e. ≥ 10 µg/dL), but to also reduce the central measure of BLLs in the target population. Specifically, the addition of sub-objective b focuses attention on reducing the geometric mean of BLLs in young children.
Additional resources about the objective.
This hyperlink will direct you to a non-governmental Website or application.
The appearance of external hyperlinks does not constitute endorsement by the United
States Department of Health & Human Services (HHS) of the hyperlinked Website
or application, or the information, products or services contained therein. Such
hyperlinks are provided consistent with the intended purpose of this HHS Website.
Visitors to the hyperlinked Website or application will be subject to the Website
or application's privacy policies. These practices may be different than those of
this HHS Website.
You will be redirected to: link